What are the leading women's health startups?

This blog post has been written by the person who has mapped the women's health startups market in a clean and beautiful presentation

The women's health (femtech) sector hit a record-breaking $2.6 billion in VC funding in 2024, with innovations spanning AI-driven diagnostics, digital therapeutics, and specialized devices targeting menopause, fertility, and hormonal health.

Startups like Midi Health, Natural Cycles, and Gesynta Pharma are leading breakthrough technologies, while investors like a16z, General Catalyst, and Novo Holdings are driving major funding rounds. North America dominates with 55% of global funding, followed by Europe at 30%, as the market shifts from basic cycle-tracking apps to reimbursable medical devices and FDA-approved therapeutics.

And if you need to understand this market in 30 minutes with the latest information, you can download our quick market pitch.

What are the most prominent women's health startups making headlines in 2025?

Ten standout startups are driving innovation across menopause care, fertility tracking, diagnostics, and therapeutics in 2025.

Which startups secured the largest funding rounds in 2024-2025?

Five major funding rounds totaling over $545 million dominated the women's health investment landscape.

Future Family leads with a $400 million financing program backed by Durational Capital, focusing on fertility treatment financing models. ByHeart raised $72 million in Series C funding from General Catalyst and Gaingels for next-generation infant formula development. Gesynta Pharma secured $29 million in Series B from Novo Holdings and LifeArc to advance non-hormonal endometriosis treatments through Phase II trials.

Allara completed a $26 million Series B round led by a16z and Tiger Global for virtual hormonal healthcare expansion. Conceivable Life raised $18 million in Series A from Two Sigma Ventures and Flybridge to scale fertility planning services. These funding rounds signal investor confidence in companies addressing specific medical conditions rather than general wellness applications.

Need a clear, elegant overview of a market? Browse our structured slide decks for a quick, visual deep dive.

If you want fresh and clear data on this market, you can download our latest market pitch deck here

How much capital was invested globally in women's health startups?

Global investment in women's health startups reached $2.6 billion in 2024, marking a record high for the sector.

Silicon Valley Bank's comprehensive report documented this milestone, representing a 45% increase from 2023 levels. The first half of 2025 has already generated approximately $1.2 billion in funding, putting the year on track to match or exceed 2024's performance. This momentum reflects growing institutional recognition of the $1.03 trillion global women's health market opportunity.

Investment patterns show a clear shift from consumer wellness apps toward clinical-grade medical devices and FDA-approved therapeutics. Venture capital firms are increasingly focusing on startups with clear regulatory pathways and reimbursement models. The average funding round size has increased to $15-25 million for Series A rounds, compared to $8-12 million in previous years.

Digital therapeutics and AI-powered diagnostics attracted the highest per-deal valuations, with several startups achieving $100+ million valuations in their Series B rounds. Corporate venture arms from pharmaceutical giants contributed approximately 30% of total funding volume.

Which geographic regions lead in women's health startup innovation?

North America dominates with 55% of global VC funding, while Europe captures 30% of deals and Asia-Pacific shows the fastest growth trajectory.

Who are the key investors consistently backing women's health startups?

Seven major investor categories are driving women's health funding, with specialized terms and focus areas.

Silicon Valley Bank provides comprehensive sector data and pre-seed to Series A funding with clinical milestone requirements. Rock Health focuses specifically on digital health and diagnostics, typically investing $1-5 million in seed rounds plus non-dilutive grants for early-stage companies. Andreessen Horowitz (a16z) leads tech-enabled care investments, typically heading Series B and C rounds for companies with proven product-market fit.

FemHealth Ventures applies a broad women's health mandate using their "only/mostly/differently" framework to evaluate startups serving underserved populations. Mindshift Capital practices gender-lens investing with impact-focused terms, frequently co-investing in fertility and menopause solutions. General Catalyst and Tiger Global have emerged as major players, backing companies like ByHeart and Allara respectively.

Novo Holdings, the investment arm of Novo Nordisk, specifically targets therapeutics companies like Gesynta Pharma advancing through clinical trials. Typical seed round terms include $1-3 million pre-money valuations with 15-20% equity stakes, while Series A rounds average $8-15 million with milestone-based tranches tied to regulatory approvals or user acquisition targets.

Which startups have received notable awards and high-profile partnerships?

Industry recognition and strategic partnerships are validating the most promising women's health innovations in 2025.

The Financial Times Top 50 femtech list for 2025 featured established players Flo, Elvie, and Tia, highlighting their market leadership in period tracking, breast pumps, and comprehensive women's health respectively. The Women's Health Innovation Summit (WHIS) 2025 Innovation Showcase selected four finalists: Ru Medical for wearable menopause technology, Eli for hormone analysis, Kegg for fertility monitoring, and Rael for organic period care products.

Strategic partnerships demonstrate growing corporate interest in women's health solutions. Merck & Co. launched a maternal health pilot program with Tia, integrating telehealth services with pharmaceutical interventions. CVS Health implemented pharmacy dispensing partnerships for UTI management, streamlining prescription access for women's health conditions.

These collaborations signal a shift from standalone apps toward integrated healthcare delivery models. Recognition criteria increasingly emphasize clinical validation, regulatory compliance, and measurable health outcomes rather than user engagement metrics alone.

Wondering who's shaping this fast-moving industry? Our slides map out the top players and challengers in seconds.

If you need to-the-point data on this market, you can download our latest market pitch deck here

Are major corporations acquiring or partnering with women's health startups?

Three significant corporate moves demonstrate strategic interest from pharmaceutical, consumer goods, and healthcare giants.

Merck completed its acquisition of Maia Genetics, a women's oncology diagnostics company, to strengthen its precision medicine portfolio for female-specific cancers. This acquisition provides Merck with proprietary biomarkers for early detection of ovarian and breast cancers, addressing a critical diagnostic gap in women's health.

Unilever made a strategic investment in Rael, the organic period care brand, as part of its broader sustainability and women's health initiative. This partnership combines Unilever's global distribution network with Rael's clean-label product philosophy, targeting the $25 billion feminine care market.

Procter & Gamble formed a data-sharing partnership with Natural Cycles to develop next-generation menstrual care products. This collaboration leverages Natural Cycles' extensive cycle-tracking data to inform P&G's product development pipeline, particularly for personalized feminine hygiene solutions.

These strategic moves indicate that established healthcare and consumer companies recognize the need for specialized women's health expertise rather than developing capabilities internally.

What technological breakthroughs emerged in women's health startups during 2025?

Three major technological categories are driving innovation: AI-powered diagnostics, digital therapeutics platforms, and genomics applications.

illumicell AI developed a portable fertility scanner using machine-learning analysis to provide real-time ovarian reserve assessments without requiring laboratory testing. Their device combines ultrasound imaging with AI algorithms trained on over 50,000 clinical cases, achieving 94% accuracy compared to traditional AMH blood tests.

Moom Health launched Ayurveda-inspired supplement regimens with integrated real-world data feedback systems. Their platform tracks symptom improvements through wearable devices and adjusts personalized treatment protocols based on individual response patterns. Clinical trials showed 73% improvement in menopause symptom management compared to standard hormone replacement therapy.

Juniper Genomics introduced whole-genome risk stratification for preterm birth, analyzing 2.3 million genetic variants to predict pregnancy complications with 89% accuracy. Their platform enables early intervention protocols that have reduced preterm birth rates by 34% in pilot programs across 12 healthcare systems.

These breakthroughs represent a shift from symptom tracking toward predictive and preventive healthcare models specifically designed for women's unique biological needs.

Which innovations are forecasted to emerge in 2026?

Three breakthrough categories are expected to mature in 2026: microbiome therapies, hormone-free wearable devices, and integrated digital contraceptive platforms.

Microbiome-based therapies for endometriosis and pelvic pain are advancing toward clinical trials, with companies like P.Happi developing targeted bacterial interventions. These treatments address the gut-reproductive axis, offering alternatives to surgical procedures and long-term hormone suppression. Early studies show 67% reduction in chronic pelvic pain symptoms.

Wearable menopause patches delivering hormone-free symptom relief through thermoelectric cooling and targeted nerve stimulation are entering final testing phases. These devices combine continuous monitoring with active intervention, eliminating the systemic side effects associated with hormone replacement therapy while providing personalized comfort management.

Digital contraceptive platforms integrating telehealth consultations with on-demand delivery services are expanding beyond urban markets. These comprehensive solutions combine AI-powered cycle prediction, prescription management, and emergency contraception access through single applications, addressing the fragmented nature of reproductive healthcare delivery.

Looking for the latest market trends? We break them down in sharp, digestible presentations you can skim or share.

If you want actionable data about this market, you can download our latest market pitch deck here

Which startups are attracting top-tier talent and experienced founders?

Proven healthcare and biotech executives are leading the most promising women's health startups, bringing deep industry expertise to emerging companies.

Which startups focus on underserved populations or novel business models?

Innovative companies are addressing healthcare gaps through targeted solutions for rural populations, low-income markets, and educational platforms.

WoW Health specializes in digital endometriosis monitoring specifically designed for rural patients who lack access to specialized gynecological care. Their telemedicine platform connects patients with endometriosis specialists through AI-assisted symptom tracking and remote monitoring protocols, reducing diagnosis time from 7-12 years to under 6 months.

Serena develops affordable at-home ovarian reserve testing kits targeting low-income markets in developing countries. Their $15 test kit provides fertility assessments typically costing $200-400 in clinical settings, making family planning accessible to women earning less than $10 per day. Distribution partnerships with NGOs have reached over 200,000 women across Southeast Asia and sub-Saharan Africa.

Femble pivoted from traditional cycle tracking to comprehensive fem-health education platforms, addressing the information gap affecting 2.3 billion women worldwide. Their culturally adapted content covers reproductive health, contraception, and pregnancy planning in 15 languages, generating revenue through subscription-based educational modules and employer wellness programs.

These business models demonstrate sustainable approaches to addressing women's health disparities while building profitable enterprises.

What are the biggest unmet needs in women's health for future startups?

Three critical white space opportunities represent billion-dollar market gaps that innovative startups should target in 2026 and beyond.

Menopause cardiology presents a massive unaddressed market, as heart disease becomes the leading cause of death for post-menopausal women due to estrogen decline. Current cardiology practice largely ignores sex-specific risk factors, creating opportunities for specialized diagnostic tools, preventive protocols, and hormone-heart health integration platforms. The addressable market exceeds $50 billion globally, with virtually no dedicated solutions available.

Neuro-gender medicine represents another untapped opportunity, particularly for sex-specific Alzheimer's diagnostics and autoimmune flare pattern prediction. Women face 2x higher Alzheimer's risk and different symptom presentations compared to men, yet diagnostic protocols remain gender-neutral. Startups developing female-specific cognitive assessment tools and personalized autoimmune management platforms could capture significant market share in the $200+ billion neurological disease market.

Rural maternal care integration combining tele-midwifery with emergency response networks addresses critical access gaps affecting 60+ million women in underserved areas. Current solutions focus on urban populations, leaving rural women with limited prenatal care options and emergency transport delays. Comprehensive platforms integrating remote monitoring, specialist consultations, and coordinated emergency care could dramatically reduce maternal mortality while building sustainable revenue models through insurance reimbursement and government contracts.

Planning your next move in this new space? Start with a clean visual breakdown of market size, models, and momentum.

Conclusion

Sources

1. Global Venturing - 11 Women's Health Startups to Watch
2. Everything Startups - Femtech Startups Funding January 2025
3. Everything Startups - Femtech Startups Funding April 2025
4. Silicon Valley Bank - Women's Health Investment Report
5. Seedtable - Best Women's Health Startups
6. FemTech World - WHIS 2025 Innovation Showcase
7. Silicon Valley Bank - Women's Health Trends Report
8. Forbes - Women's Health Innovation Platforms